Statistics for Rapid development of optimized recombinant adenoviral vaccines for biosafety level 4 viruses

Total visits

views
Rapid development of optimized recombinant adenoviral vaccines for biosafety level 4 viruses 650

Total visits per month

views
November 2023 3
December 2023 0
January 2024 0
February 2024 0
March 2024 0
April 2024 0
May 2024 0

File Visits

views
sahib_mickey.pdf 1267

Top country views

views
United States 226
Canada 79
China 70
Germany 56
United Kingdom 31
Ireland 16
India 12
Iran 10
Netherlands 10
Sweden 9
Finland 8
France 8
Turkey 8
Pakistan 7
Ukraine 6
Colombia 5
South Africa 4
Australia 3
Hong Kong SAR China 3
Philippines 3
United Arab Emirates 2
Austria 2
Bangladesh 2
Côte d’Ivoire 2
Cyprus 2
Spain 2
Greece 2
Italy 2
Singapore 2
Vietnam 2
Belgium 1
Botswana 1
Ghana 1
Iraq 1
South Korea 1
Monaco 1
Thailand 1
Taiwan 1

Top city views

views
Winnipeg 51
Redwood City 42
Ashburn 37
Xian 26
Beijing 21
Palo Alto 20
Dublin 16
Redmond 12
Inglewood 11
Boston 8
Edmonton 8
Seattle 8
Mountain View 7
Munich 7
Philadelphia 7
Helsinki 6
Tianjin 6
Belfast 5
Galveston 5
Gatineau 5
London 5
Ottawa 5
Zhengzhou 5
Noida 4
Oxford 4
Rawalpindi 4
Barranquilla 3
Central 3
Los Angeles 3
Abidjan 2
Angeles City 2
Bloemfontein 2
Bristol 2
Brooklyn 2
Burton-on-Trent 2
Caltagirone 2
Chongqing 2
Dallas 2
Denver 2
Des Moines 2
Durban 2
Düsseldorf 2
Eskisehir 2
Fort Saskatchewan 2
Hanoi 2
Honolulu 2
Houston 2
Izmir 2
La Jolla 2
Lahore 2
Landshut 2
Marquette 2
Mumbai 2
Offenburg 2
Pasadena 2
Saint Robert 2
Seabrook 2
Shanghai 2
Shenzhen 2
Tehran 2
Vienna 2
Östersund 2
Accra 1
Alexandria 1
Algete 1
Amsterdam 1
Ankara 1
Athabasca 1
Athens 1
Atlanta 1
Bangkok 1
Belmont 1
Bielefeld 1
Brussels 1
Chennai 1
Cheshire 1
Chicago 1
Corvallis 1
Decatur 1
Edinburgh 1
Finsbury 1
Frankfurt am Main 1
Gaborone 1
Heidelberg 1
Jaipur 1
Kecioeren 1
Kocasinan 1
Kolkata 1
Laval 1
Lingenfeld 1
Manila 1
Mannheim 1
Marratxí 1
Melbourne 1
Monaco 1
Morlenbach 1
Mudau 1
Mundamveli 1
Naaldwijk 1
Nagold 1